Mark Winderlich - 15 Apr 2024 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Development Officer
Signature
/s/ Reinhard Kandera, Attorney-in-Fact
Issuer symbol
HOOK
Transactions as of
15 Apr 2024
Net transactions value
$0
Form type
4
Filing time
17 Apr 2024, 16:15:25 UTC
Previous filing
11 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 15 Apr 2024 Common Stock 250,000 $0.7600 Direct F1
transaction HOOK Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 15 Apr 2024 Common Stock 50,000 $0.7600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter.